Ghulam Md Ashraf – författare

The human brain is made up of billions of neurons that communicate with each other through chemical messengers, which are referred to as neuroactive substances. These neuroactive substances include neurotransmitters, neuromodulators, and neurohormones. Some neurotransmitters also act as neuromodulators and neurohormones. It is unlikely that there would ever be a consensus about the meanings of these neuroactive substances, including neurotransmitters, since the term ‘neurotransmitter’ has traditionally been used very loosely indeed, to include neurotransmitters, neurohormones, and neuromodulators. Any alterations in the functioning of these neuroactive substances can cause diseases.

The brain is the ultimate center that regulates all neurological and behavioral aspects of the body through neuronal communications mediated via various neurochemicals. Thus, neurological and psychiatric disorders are, in most cases, the result of disturbed neurochemical balance. Besides the multifaceted involvement of billions of neuronal cells, the central nervous system is a complex organization with a diverse number of neurotransmitter systems, as compared to the autonomic nervous system, in which the parasympathetic system works on the ‘rest and digest’ phenomenon, and the sympathetic system works on the ‘fight or flight’ phenomenon. There are more than 20 neurotransmitter systems and multiple receptors for each neurotransmitter. Any alterations in neurochemical balance are expressed in the form of neurological or psychiatric disorders such as epilepsy, Parkinson’s disease, Alzheimer’s disease, psychosis, depression, etc. Acetylcholine, noradrenaline, dopamine, and 5-HT are of the utmost importance among neurotransmitters for their profound role in the pathogenesis of various neurological and psychiatric disorders in humans. Yet the involvement of various proteins and peptides, such as neurotrophic factors, growth factors, and endogenous chemical compounds, cannot be ignored.

Day by day, the suffering of people due to an imbalance of neurotransmitters is increasing. Various factors, for example stress, diet, genetics, and toxins such as alcohol and nicotine, contribute to this imbalance. This imbalance may lead to mental health complaints. The main purpose of this book is to give a comprehensive overview of the neurological diseases associated with neurochemical imbalances. This book will help readers gain a comprehensive understanding of neuronal signaling and related neurological disorders, as well as status and future opportunities and challenges. It will provide a brief account of neurotransmission, as either a study or high-yield revision aid.

The human brain is made up of billions of neurons that communicate with each other through chemical messengers, which are referred to as neuroactive substances. These neuroactive substances include neurotransmitters, neuromodulators, and neurohormones. Some neurotransmitters also act as neuromodulators and neurohormones. It is unlikely that there would ever be a consensus about the meanings of these neuroactive substances, including neurotransmitters, since the term ‘neurotransmitter’ has traditionally been used very loosely indeed, to include neurotransmitters, neurohormones, and neuromodulators. Any alterations in the functioning of these neuroactive substances can cause diseases.

The brain is the ultimate center that regulates all neurological and behavioral aspects of the body through neuronal communications mediated via various neurochemicals. Thus, neurological and psychiatric disorders are, in most cases, the result of disturbed neurochemical balance. Besides the multifaceted involvement of billions of neuronal cells, the central nervous system is a complex organization with a diverse number of neurotransmitter systems, as compared to the autonomic nervous system, in which the parasympathetic system works on the ‘rest and digest’ phenomenon, and the sympathetic system works on the ‘fight or flight’ phenomenon. There are more than 20 neurotransmitter systems and multiple receptors for each neurotransmitter. Any alterations in neurochemical balance are expressed in the form of neurological or psychiatric disorders such as epilepsy, Parkinson’s disease, Alzheimer’s disease, psychosis, depression, etc. Acetylcholine, noradrenaline, dopamine, and 5-HT are of the utmost importance among neurotransmitters for their profound role in the pathogenesis of various neurological and psychiatric disorders in humans. Yet the involvement of various proteins and peptides, such as neurotrophic factors, growth factors, and endogenous chemical compounds, cannot be ignored.

Day by day, the suffering of people due to an imbalance of neurotransmitters is increasing. Various factors, for example stress, diet, genetics, and toxins such as alcohol and nicotine, contribute to this imbalance. This imbalance may lead to mental health complaints. The main purpose of this book is to give a comprehensive overview of the neurological diseases associated with neurochemical imbalances. This book will help readers gain a comprehensive understanding of neuronal signaling and related neurological disorders, as well as status and future opportunities and challenges. It will provide a brief account of neurotransmission, as either a study or high-yield revision aid.

This book discusses the latest research into the highly prevalent neurodevelopmental disease most commonly associated with aging: Alzheimer’s disease (AD). Even after years of research, Alzheimer’s disease is still far from being cured. It presents a range of common symptoms in the form of behavioral and cognitive impairments. This book describes the symptoms and the biology behind them. 

The contents covers latest findings on the genetics involved and various factors and pathways influencing disease development. It also covers various non-pharmacological therapies like immunotherapy, use of natural products, and employing nanotechnology in both the detection and treatment of AD. This book also highlights the role of diet and nutrition in healthy aging. Given its scope, it offers a valuable asset for researchers and clinicians alike. 

This book talks about the multidimensional biological etiology of Alzheimer’s disease and autism spectrum disorder which leads to distinctive ways of perception, thinking and learning in affected individuals. It provides a deeper emphasis on the need for early diagnosis, continuous assessment of patients and the proper educational methods and environment required towards enabling people affected with these disorders capable of evolving and learning.

This book explores alternative solutions for autism spectrum disorder based on the theory of brain plasticity, the relationship between the gut microbiota and the central nervous system along with genetic factors and toxic metal exposures which are responsible for the oxidative damage resulting in a decreased ability of the patients to use objects or response to auditory stimuli. It also identifies and provides the latest research towards dealing with memory loss, which is the first sign of cognitive impairment followed by behavioral disturbances. These symptoms are associated with a rigorous neuronal decline and the appearance of two brain lesions, senile plaques and neurofibrillary tangles, which are mainly composed of Aβ and hyper phosphorylated tau protein respectively. This book also provides the latest research towards reducing autism disorder severity such as targeting the disease with symptomatic treatments such as cholinesterase inhibitors, NMDA receptor antagonist, β-secretase and γ-secretase inhibitors, α-secretase stimulators, tau inhibitors, immunotherapy, nutraceuticals, and nano drugs.

This book will not only be a good resource for professors and lecturers teaching in the area of neuroscience, medicine, biochemistry, neuroinformatics, and nanotechnology, etc. but also for professionals working in the field of occupational therapy and geriatric clinics and rehabilitation.

This informative book discusses the latest research on the risk factors and therapeutics in dementia. WHO calls dementia a public health priority. Dementia manifests as a group of symptoms associated with decline in memory or other thinking skills and is severe enough to reduce a person''s ability to perform everyday activities. It occurs frequently among elderly people, but it is not necessarily part of the normal aging process. The book has been divided into two broad sections. The first section reviews the risk factors involved in developing dementia, including various medical conditions, lifestyle choices, as well as genetics. The latter section describes various therapeutic interventions in dementia. Although there is no known cure for dementia, this book underlines the current treatment strategies that could momentarily reduce the symptoms and improve the quality of life of the patients. This book highlights the global effort to find better ways to halt the progression of dementia and develop novel therapeutic strategies. 

The book would be an interesting read for advanced graduate students and researchers working in the field of neuroscience, genetics, and medicine. It will generate good interest to neurologists, psychiatrists, geriatricians, cardiologists, internal medicine practitioners, epidemiologist, and public health workers.

This book is a comprehensive guide to the pathology, underlying mechanisms, and treatment options for Alzheimer''s disease (AD). The book starts with an introduction to the basic anatomy and physiology of the central nervous system, followed by an overview of the types, classifications, and basic concepts of neurodegenerative disorders. The epidemiology, etiology, risk factors, and future predictions of AD have been covered in detail. The book then delves into the pathophysiology and underlying mechanisms of plaque formation and explores the correlation of AD with other psychological and non-psychological conditions. The chapters also explore the diagnosis of AD, including types of plaques and their detection, imaging techniques, and other tests. The book also covers traditional therapies for AD and explores the potential application of nanotechnology in AD treatment. The book also covers animal models and ethics in the testing of drugs for AD, regulatory guidelines, and the approval process for drugs and formulations for AD. Prevention and reduction of AD risk are explored, including lifestyle changes, dietary changes, supplements, natural medicines (phytoconstituents), and probiotics as the future of AD. The book concludes with a discussion of future barriers and possible solutions with recent advances in the field of AD. This book is an essential guide for students, researchers, and healthcare professionals interested in Alzheimer''s disease research.